Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Subhasree Kar

Should You Buy Shares of Cronos Group (CRON) in July?

While Canadian cannabinoid company Cronos Group Inc. (CRON) has been expanding its business, that’s not paying off well. The company is struggling with lower cannabis flower sales in its Rest of the World segment and a decline in revenue in the U.S. segment.

The company reported a 20% year-over-year drop in net revenue at $20.14 million for the quarter ending March 31. Gross profit for the same period stood at a dwindled $2.38 million, marking a decrease of $4.55 million compared to the prior-year quarter. Also, its bottom line remained in the red.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.